Literature DB >> 28455751

National trends and outcomes of autologous in vitro fertilization cycles among women ages 40 years and older.

Heather Hipp1,2, Sara Crawford3, Jennifer F Kawwass4,3, Sheree L Boulet3, David A Grainger5, Dmitry M Kissin3, Denise Jamieson3.   

Abstract

PURPOSE: The purpose of the study was to describe trends in and investigate variables associated with clinical pregnancy and live birth in autologous in vitro fertilization (IVF) cycles among women ≥40 years.
METHODS: We used autologous IVF cycle data from the National ART Surveillance System (NASS) for women ≥40 years at cycle start. We assessed trends in fresh and frozen cycles (n = 371,536) from 1996 to 2013. We reported perinatal outcomes and determined variables associated with clinical pregnancy and live birth in fresh cycles between 2007 and 2013.
RESULTS: From 1996 to 2013, the total number of cycles in women ≥40 years increased from 8672 to 28,883 (p < 0.0001), with frozen cycles almost tripling in the last 8 years. Cycles in women ≥40 years accounted for 16.0% of all cycles in 1996 and 21.0% in 2013 (p < 0.0001). For fresh cycles from 2007 to 2013 (n = 157,890), the cancelation rate was 17.1%. Among cycles resulting in transfer (n = 112,414), the live birth rate was 16.1%. The following were associated with higher live birth rates: multiparity, fewer prior ART cycles, use of standard agonist or antagonist stimulation, lower gonadotropin dose, ovarian hyperstimulation syndrome, more oocytes retrieved, use of pre-implantation genetic screening/diagnosis, transferring more and/or blastocyst stage embryos, and cryopreserving more supernumerary embryos. Of the singleton infants born (n = 14,992), 86.9% were full term and 88.3% normal birth weight.
CONCLUSIONS: The NASS allows for a comprehensive description of IVF cycles in women ≥40 years in the USA. Although live birth rate is less than 20%, identifying factors associated with IVF success can facilitate treatment option counseling.

Entities:  

Keywords:  40 years and over; In vitro fertilization (IVF); Infertility; Older women

Mesh:

Year:  2017        PMID: 28455751      PMCID: PMC5476541          DOI: 10.1007/s10815-017-0926-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  25 in total

1.  Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.

Authors:  Valerie L Baker; Morton B Brown; Barbara Luke; George W Smith; James J Ireland
Journal:  Fertil Steril       Date:  2015-08-18       Impact factor: 7.329

2.  Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology.

Authors:  Anna Lena Wennberg; Signe Opdahl; Christina Bergh; Anna-Karina Aaris Henningsen; Mika Gissler; Liv Bente Romundstad; Anja Pinborg; Aila Tiitinen; Rolv Skjærven; Ulla-Britt Wennerholm
Journal:  Fertil Steril       Date:  2016-07-09       Impact factor: 7.329

3.  Too old to have children? Lessons from natural fertility populations.

Authors:  Marinus J C Eijkemans; Frans van Poppel; Dik F Habbema; Ken R Smith; Henri Leridon; Egbert R te Velde
Journal:  Hum Reprod       Date:  2014-03-27       Impact factor: 6.918

4.  Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?

Authors:  Vinay Gunnala; David E Reichman; Laura Meyer; Owen K Davis; Zev Rosenwaks
Journal:  Fertil Steril       Date:  2014-10-22       Impact factor: 7.329

5.  A significant linear association exists between advanced maternal age and adverse perinatal outcome.

Authors:  Shimrit Salem Yaniv; Amalia Levy; Arnon Wiznitzer; Gershon Holcberg; Moshe Mazor; Eyal Sheiner
Journal:  Arch Gynecol Obstet       Date:  2010-04-08       Impact factor: 2.344

6.  Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.

Authors:  A Tsafrir; A Simon; A Revel; B Reubinoff; A Lewin; N Laufer
Journal:  Reprod Biomed Online       Date:  2007-03       Impact factor: 3.828

7.  Impact of female age and nulligravidity on fecundity in an older reproductive age cohort.

Authors:  Anne Z Steiner; Anne Marie Z Jukic
Journal:  Fertil Steril       Date:  2016-03-05       Impact factor: 7.329

8.  Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above.

Authors:  Gamal Serour; Ragaa Mansour; Ahmed Serour; Mona Aboulghar; Yahia Amin; Omnia Kamal; Hesham Al-Inany; Mohamed Aboulghar
Journal:  Fertil Steril       Date:  2009-11-06       Impact factor: 7.329

9.  Effect of Embryo Banking on U.S. National Assisted Reproductive Technology Live Birth Rates.

Authors:  Vitaly A Kushnir; David H Barad; David F Albertini; Sarah K Darmon; Norbert Gleicher
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

10.  Effectiveness of in vitro fertilization in women with previous tubal sterilization.

Authors:  Eva Malacova; Anna Kemp; Roger Hart; Khadra Jama-Alol; David B Preen
Journal:  Contraception       Date:  2014-12-12       Impact factor: 3.375

View more
  6 in total

1.  Health outcomes for Massachusetts infants after fresh versus frozen embryo transfer.

Authors:  Sunah S Hwang; Dmitry Dukhovny; Daksha Gopal; Howard Cabral; Hafsatou Diop; Charles C Coddington; Judy E Stern
Journal:  Fertil Steril       Date:  2019-08-26       Impact factor: 7.329

2.  Trends and Outcomes for Preimplantation Genetic Testing in the United States, 2014-2018.

Authors:  Heather S Hipp; Sara Crawford; Sheree Boulet; James Toner; Amy A E Sparks; Jennifer F Kawwass
Journal:  JAMA       Date:  2022-04-05       Impact factor: 157.335

3.  Adjuvant Vaginal Use of Sildenafil Citrate in a Hormone Replacement Cycle Improved Live Birth Rates Among 10,069 Women During First Frozen Embryo Transfers.

Authors:  Yu Tao; Ningling Wang
Journal:  Drug Des Devel Ther       Date:  2020-12-01       Impact factor: 4.162

4.  Frozen-thawed embryo transfers: time to adopt a more "natural" approach?

Authors:  Bruce D Pier; Logan M Havemann; Alexander M Quaas; Ryan J Heitmann
Journal:  J Assist Reprod Genet       Date:  2021-03-19       Impact factor: 3.357

5.  Predictive Factors for Live Birth in Autologous in Vitro Fertilization Cycles in Women Aged 40 Years and Older.

Authors:  Milan Reljič; Vida Gavrić Lovrec
Journal:  Zdr Varst       Date:  2019-10-01

6.  Can high antimüllerian hormone mitigate some of the age-related decline in live birth rates? The association between antimüllerian hormone and live birth among women over 40 undergoing in vitro fertilization.

Authors:  Benjamin S Harris; Kelly S Acharya; Jeremy M Weber; Tracy Truong; Jennifer L Eaton
Journal:  F S Rep       Date:  2021-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.